Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Assets Average (2021 - 2025)

Historic Assets Average for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $13.2 million.

  • Coeptis Therapeutics Holdings' Assets Average changed N/A to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 795.22% up from last year.
  • Coeptis Therapeutics Holdings' Assets Average amounted to $13.2 million in Q3 2025.
  • Coeptis Therapeutics Holdings' 5-year Assets Average high stood at $76.5 million for Q2 2021, and its period low was $5.9 million during Q4 2023.
  • Over the past 5 years, Coeptis Therapeutics Holdings' median Assets Average value was $13.0 million (recorded in 2025), while the average stood at $26.5 million.
  • Its Assets Average has fluctuated over the past 5 years, first crashed by 8799.39% in 2023, then surged by 6012.22% in 2025.
  • Coeptis Therapeutics Holdings' Assets Average (Quarter) stood at $41.6 million in 2021, then tumbled by 50.42% to $20.6 million in 2022, then tumbled by 71.51% to $5.9 million in 2023, then soared by 52.14% to $8.9 million in 2024, then surged by 47.63% to $13.2 million in 2025.
  • Its Assets Average was $13.2 million in Q3 2025, compared to $12.8 million in Q2 2025 and $11.2 million in Q1 2025.